Shareholders In Guangxi Hechi Chemical (SZSE:000953) Should Look Beyond Earnings For The Full Story
Shareholders In Guangxi Hechi Chemical (SZSE:000953) Should Look Beyond Earnings For The Full Story
After announcing healthy earnings, Guangxi Hechi Chemical Co., Ltd's (SZSE:000953) stock rose over the last week. Despite the strong profit numbers, we believe that there are some deeper issues which investors should look into.
在宣佈良好收益之後,河化股份(SZSE:000953)的股票在上週上漲。儘管利潤數字強勁,我們認爲投資者應該深入了解一些更深層次的問題。
Zooming In On Guangxi Hechi Chemical's Earnings
深入解讀河化股份的盈利
In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. This ratio tells us how much of a company's profit is not backed by free cashflow.
在高級金融領域,衡量公司將報告的利潤轉化爲自由現金流(FCF)的關鍵比率是應計比率(從現金流量中)。簡而言之,此比率將FCF從淨利潤中扣除,然後將該數字除以該期間內公司的平均營運資產。這個比率告訴我們公司利潤中有多少不由自由現金流支持。
Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
因此,一家公司有負應計比率實際上是一件好事,但是如果它的應計比率爲正,那是一件壞事。這並不意味着我們應該擔心應計比率爲正,但值得注意的是,如果應計比率相當高,有一些學術證據表明,這是一個不利於近期利潤的壞跡象。
Guangxi Hechi Chemical has an accrual ratio of 0.48 for the year to September 2024. Statistically speaking, that's a real negative for future earnings. To wit, the company did not generate one whit of free cashflow in that time. Over the last year it actually had negative free cash flow of CN¥15m, in contrast to the aforementioned profit of CN¥71.6m. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of CN¥15m, this year, indicates high risk. Having said that, there is more to the story. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part. One positive for Guangxi Hechi Chemical shareholders is that it's accrual ratio was significantly better last year, providing reason to believe that it may return to stronger cash conversion in the future. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.
截至2024年9月,河化股份的計提比率爲0.48。統計數據顯示,這對未來盈利實際上是一個負面因素。換句話說,公司在那段時間內沒有產生任何自由現金流。在過去一年中,其實際上出現了1500萬人民幣的負自由現金流,相比之下提到的7160萬人民幣的利潤。基於去年負自由現金流的情況,我們想象一些股東可能會想知道,今年的1500萬人民幣的現金消耗是否意味着高風險。話雖如此,故事還有更多情節。計提比率反映了異常項目對法定利潤的影響,至少在一定程度上是如此。對河化股份股東的一個正面因素是,其計提比率去年明顯更好,這讓人有理由相信,未來可能會恢復更強勁的現金轉換。如果情況確實如此,股東應尋找當前年度現金流相對於利潤的改善。
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Guangxi Hechi Chemical.
注意:我們始終建議投資者檢查資產負債表的實力。單擊此處查看我們對河化股份資產負債表分析。
The Impact Of Unusual Items On Profit
除了稀釋之外,還應該注意的是,萬集科技在過去12個月中因不尋常項目獲得了價值人民幣3.5萬元的利潤。雖然我們希望看到利潤增加,但當這些不尋常項目對利潤做出重大貢獻時,我們會更加謹慎。我們對全球大部分上市公司的數據進行了分析,發現不尋常項目往往是一次性的。這正如我們所期望的那樣,因爲這些提升被描述爲"不尋常"。相對於其利潤而言,萬集科技在2021年12月前的不尋常項目貢獻大。因此,我們可以推斷出,這些不尋常項目正在使其財務利潤顯著增強。
Given the accrual ratio, it's not overly surprising that Guangxi Hechi Chemical's profit was boosted by unusual items worth CN¥88m in the last twelve months. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Guangxi Hechi Chemical had a rather significant contribution from unusual items relative to its profit to September 2024. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.
考慮到應計比率,廣西河化股份過去12個月的利潤受到價值8,800萬人民幣的飛凡項目的推動,這並不讓人過分驚訝。我們無法否認,更高的利潤通常使我們感到樂觀,但我們更希望利潤能夠持續增長。當我們分析全球大多數上市公司時,我們發現重大的非常飛凡項目通常不會重複。而且正如你所期望的那樣,由於這些提振被描述爲'非常飛凡'。相比其2024年9月份的利潤,廣西河化股份有一個相當顯著的非常飛凡項目貢獻。因此,我們可以推斷出這些非常飛凡項目使其法定利潤比原本強大得多。
Our Take On Guangxi Hechi Chemical's Profit Performance
我們對廣西河化股份利潤表現的看法
Summing up, Guangxi Hechi Chemical received a nice boost to profit from unusual items, but could not match its paper profit with free cash flow. For all the reasons mentioned above, we think that, at a glance, Guangxi Hechi Chemical's statutory profits could be considered to be low quality, because they are likely to give investors an overly positive impression of the company. So while earnings quality is important, it's equally important to consider the risks facing Guangxi Hechi Chemical at this point in time. At Simply Wall St, we found 2 warning signs for Guangxi Hechi Chemical and we think they deserve your attention.
總結一下,廣西河化股份從非常飛凡項目中獲得了一筆不小的利潤,但無法將其紙面利潤與自由現金流相匹配。由於上述所有原因,我們認爲乍一看,廣西河化股份的法定利潤可能被認爲質量較低,因爲這可能會讓投資者對公司產生過分積極的印象。因此,儘管盈利質量很重要,但同樣重要的是要考慮目前對廣西河化股份存在的風險。在Simply Wall St,我們發現了2個關於廣西河化股份的警示信號,我們認爲它們值得您關注。
Our examination of Guangxi Hechi Chemical has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
我們對廣西河化股份的審查主要集中在某些因素上,這些因素可能使其收益看起來比實際情況更好。基於這一點,我們對此有些持懷疑態度。但還有很多其他方法可以幫助您了解一家公司。有些人認爲股東回報率高是一個優質業務的良好跡象。儘管這可能需要您做一些調查,您可能會發現這個免費的公司集合(宣稱具有較高股東回報率)或這個持有大量內部股份的股票列表對您有用。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。